COMP <GO>
ALL vs BRK-B // 10Y YIELD & FRED MACRO BETA
Allstate Corporation (The) (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: ALL 8
— BRK-B 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: ALL
LAST: $259.87 (+1.54%) • MKT CAP: $64.71B
macro-sensitivity
0.91
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
macro-sensitivity
0.61
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALL VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALL | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.20% | 11.47% | +6.73 | ALL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.0x | 9.7x | -2.68 | ALL | /valuation <GO> |
| Free Cash Flow Yield | 15.27% | 2.09% | +13.18 | ALL | /fcf-yield <GO> |
| Operating Margin | 18.30% | 27.80% | -9.50 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 15.00% | 22.30% | -7.30 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 5.60% | 3.93% | +1.67 | ALL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.60% | 0.00% | +1.60 | ALL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.24 | 2.85 | -0.61 | BRK-B | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | ALL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 3.55% | +3.05 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.3 | 66.8 | -1.47 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.91 | 0.61 | +0.30 | ALL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.0x | 24.3x | -18.34 | ALL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $64.71B | $1.16T | -$1.09T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALL REV | BRK-B REV | ALL GROSS % | BRK-B GROSS % | ALL FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $67.69B | $371.44B | 44.0% | — | $9.88B | $25.04B |
| FY 2024 | $64.11B | $371.43B | 44.0% | — | $8.72B | $11.62B |
| FY 2023 | $57.09B | $364.48B | 44.0% | — | $1.66B | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALL // BETA 0.91
BRK-B // BETA 0.61